SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Harmon who wrote (1661)11/11/1998 9:51:00 AM
From: Walter Morton  Read Replies (1) of 2742
 
I guess being one of, a never growing, 740+ shareholders of CIST does not matter. HRLY, for example, has only 1000 shareholders and their stock price is $10. They only have about $2 million in cash, but they have positive earnings per share and 20 million less shares outstanding.

It would only cost CIST about $5 million to buy back 20 million shares. CIST can handle that, but can they make a profit?

Steve, can I get your support on a 20 million share buyback? Of course, only in a year when CIST makes a profit.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News